Psoriasis

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• Types of Psoriasis
• Causes
• Risk Factors
• Diagnosis
• Treatment
• Topical Medications
• Systemic Medications
• Phototherapy
• Managing Psoriasis
• Outlook
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Treatment Psoriasis that develops on the hands or feet is often very difficult to treat. However, an advanced clinical trial showed that a medication called efalizumab (Raptiva) effectively cleared or nearly cleared moderate-to-severe symptoms in adults after 12 weeks. Several studies have shown that most people with severe psoriasis who are treated with infliximab (Remicade) have significant improvement in symptoms by week 10. - 0 Comments

Systemic lupus erythematosus

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• Causes
• Risk Factors
• Symptoms
• Complications
• Diagnosis
• Treatment
• Treatment for Cutaneous and...
• Treatment for Severe SLE...
• Lifestyle Changes
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Systematic Lupus Erythematosus (SLE) SLE is an autoimmune disease that causes a chronic inflammatory condition. The inflammation triggered by SLE affects many organs in the body, including skin, joints, kidneys, lung, and nervous system. Women, especially African-American and Asian women, are at highest risk for developing SLE. - 0 Comments

Diabetes - type 1

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• Causes
• Risk Factors
• Symptoms
• Life-Threatening Complicati...
• Diagnosis
• Dietary Goals and Exercise...
• Treatment
• Monitoring Tests
• Long-Term Complications
• Transplantation Procedures...
• Prevention
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights New Continuous Glucose Meter System In 2007, the FDA approved the STS-7 System, which monitors glucose levels every 5 minutes during a 7-day period. The STS-7 System, like other continuous glucose meter systems, is designed to be used in combination with traditional fingerstick tests and meters. It does not replace them. - 3 Comments

Urinary incontinence

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• Stress Incontinence
• Urge Incontinence
• Overflow Incontinence
• Functional Incontinence
• Risk Factors
• Diagnosis
• Prognosis
• Treatment
• Lifestyle Changes
• Other Treatments
• Behavioral Treatments
• Medications
• Surgery
• Other Procedures
• Catheters and Collection De...
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Sling Procedure Versus Burch Colposuspension The sling procedure is better than Burch colposuspension in treating stress incontinence but may cause more post-operative urinary complications, according to results from an important 2007 New England Journal of Medicine study. In the first large-scale clinical trial to directly compare these two types of surgery, 47% of women who underwent the sling procedure had no urinary incontinence 2 years after surgery, compared with 38% of women who received the Burch procedure. However, 63% of women who had the sling procedure (and 47% of women who underwent the Burch procedure) experienced urinary tract infections following surgery. - 0 Comments

Sickle cell disease

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• Risk Factors
• Symptoms
• Diagnosis
• Outlook
• Complications
• Treatment
• Prevention and Lifestyle Ch...
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Screening for Sickle Cell Disease The United States Preventive Services Task Force’s 2007 guidelines recommend that all newborn infants be screened for sickle cell disease. (In the United States, most states require hospitals to perform this test.) Early detection of sickle cell disease ensures that babies will be given treatment to prevent infections. Sickle cell disease is an inherited condition. - 3 Comments

Birth control options for women

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• Oral Contraception
• Implant Contraception
• Injected Contraception
• Intrauterine Devices (IUDs)...
• Spermicidal and Barrier Con...
• Natural Family Planning Met...
• Emergency Contraception
• Female Sterilization
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights First "No-Period" Birth Control Pill Approved In May 2007, the Food and Drug Administration approved Lybrel, the first birth control pill that completely eliminates monthly menstrual periods. Lybrel contains low doses of the estrogen estradiol and the progestin levonorgestrol. The active pills are taken 365 days a year with no inactive pill breaks. - 1 Comment